We are pleased to announce that our new, state-of-the-art production line in Milford, MA, is now fully operational! This expansion is the largest in our history and doubles our global capacity to meet the growing demand for biopharmaceuticals that support patients with rare and serious diseases. The first major client project is already underway, and we continue to welcome new projects and clients. Interested? Then get in touch and find out how we can support you. https://lnkd.in/ecYrZ-Md
Benedikt von Braunmühl, CEO of Rentschler Biopharma SE, commented: “As a fifth-generation, family-owned company, we stand at the forefront of manufacturing innovative therapies for patients with serious and rare diseases worldwide. The completion of our new, state-of-the-art production line is an important milestone for our company and emphasizes Rentschler Biopharma’s strong capabilities in the U.S. Our clients are our partners, and we are working with them to empower tomorrow’s therapies today. Indeed, in 2023, Rentschler Biopharma was proud to contribute to nearly 25% of the biopharmaceuticals approved by the U.S. FDA. I would like to thank our teams on both sides of the Atlantic who worked tirelessly together to get this important facility online.”
Tom Roberts, President of Rentschler Biopharma Inc. and General Manager U.S. noted: “Our new line is vital to growing our business and effectively serving the U.S. market, and I am excited about bringing in new clients as well as expanding our support of existing ones with a reliability they can trust. I also would like to extend my gratitude to the entire team for their strong support in getting this important new production line up and running. We are embarking on a new stage in our long and successful history and are poised to tackle the most complex challenges in biopharmaceutical development and manufacturing. In light of evolving industry legislation, we remain committed to supporting our clients responsibly and contributing positively to both national interests and global health advancements.”
RentschlerBiopharma CDMO ReliabilityYouCanTrust
https://lnkd.in/gjEFWqXA
RENTSCHLER BIOPHARMA ANNOUNCES NEW STATE-OF-THE-ART PRODUCTION LINE IN MASSACHUSETTS IS FULLY OPERATIONAL!
Jul 11, 2024
This expansion is the largest in our history and doubles our global capacity to meet the growing demand for biopharmaceuticals that support patients with rare and serious diseases.
Posted by Rentschler Biopharma Inc